Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Rationale: Chronic musculoskeletal pain (CMP) is a common and disabling condition. Physiotherapy is the most frequently administered non-pharmacological treatment option for patients with CMP and recently virtual reality (VR) was introduced in physiotherapy care as a novel treatment modality. Proper communication about physiotherapy treatment (modalities) is important to improve treatment outcomes, by applying placebo effects enhancing communication and avoiding nocebo effects enhancing communication. However, yet is still unknown to what extent this applies to communication of physiotherapists about VR in patients with CMP.
Objective: To determine the effect of physiotherapists' placebo or nocebo therapeutic communication about VR, on treatment credibility and expectation in patients with CMP
Study design: Web-based randomized controlled trial.
Study population: 100 participants
Intervention: The placebo intervention group will be shown an educational video about VR, containing placebo effects enhancing verbal language. The nocebo intervention group will be shown an educational video about VR, containing nocebo effects enhancing verbal language.
Primary study parameters: The primary study parameters are treatment credibility and treatment expectation. Treatment credibility and treatment expectations will be measured using the Dutch credibility and expectancy questionnaire (CEQ).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo group | Experimental | The placebo intervention group will be shown an online educational VR video. |
|
| Nocebo group | Active Comparator | The nocebo intervention group will be shown an online educational VR video. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Video placebo communication | Other | The placebo communication video comprises of an educational VR video containing placebo enhancing verbal language. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in treatment expectancy measured using the Credibility and Expectancy Questionnaire (CEQ) | This questionnaire on treatment expectancy scores from 6 (lowest expectancy) to 54 (highest expectancy) | Baseline and immediately after the intervention |
| Change in treatment credibility measured using the Credibility and Expectancy Questionnaire (CEQ) | This questionnaire on treatment credibility scores from 5 (lowest credibility) to 45 (highest credibility) | Baseline and immediately after the intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Change in openness to VR measured using a single question | The question "would you be open to treatment with therapeutic VR" was scored with a yes/no | Baseline and immediately after the intervention |
| Change in pain intensity measured using the Numeric Pain Rating Scale (NPRS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bart Staal, PhD | HAN University of Applied Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| HAN University of Applied Sciences | Nijmegen | Overijssel | 6525EN | Netherlands |
Not planned to share IPD
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003142 | Communication |
| D059350 | Chronic Pain |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Video nocebo communication | Other | The nocebo communication video comprises of an educational VR video containing nocebo stimulating verbal language. |
|
This questionnaire on pain intensity scores from 0 (no pain) to 10 (maximal pain) |
| Baseline and immediately after the intervention |
| D013568 |
| Pathological Conditions, Signs and Symptoms |